These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 28605330

  • 1. Effect of Antihypertensive Drug Treatment on Oxidative Stress Markers in Heart of Spontaneously Hypertensive Rat Models.
    Yusoff NSN, Mustapha Z, Sharif SET, Govindasamy C, Sirajudeen KNS.
    J Environ Pathol Toxicol Oncol; 2017; 36(1):43-53. PubMed ID: 28605330
    [Abstract] [Full Text] [Related]

  • 2. Effect of the antihypertensive drug enalapril on oxidative stress markers and antioxidant enzymes in kidney of spontaneously hypertensive rat.
    Chandran G, Sirajudeen KN, Yusoff NS, Swamy M, Samarendra MS.
    Oxid Med Cell Longev; 2014; 2014():608512. PubMed ID: 25254079
    [Abstract] [Full Text] [Related]

  • 3. Effect of Clonidine (an antihypertensive drug) treatment on oxidative stress markers in the heart of spontaneously hypertensive rats.
    Nik Yusoff NS, Mustapha Z, Govindasamy C, Sirajudeen KN.
    Oxid Med Cell Longev; 2013; 2013():927214. PubMed ID: 23766863
    [Abstract] [Full Text] [Related]

  • 4. Short-term ACE inhibition confers long-term protection against target organ damage.
    Hale TM, Robertson SJ, Burns KD, deBlois D.
    Hypertens Res; 2012 Jun; 35(6):604-10. PubMed ID: 22318205
    [Abstract] [Full Text] [Related]

  • 5. Renoprotective effects of felodipine and/or enalapril in spontaneously hypertensive rats with and without L-NAME.
    Francischetti A, Ono H, Frohlich ED.
    Hypertension; 1998 Mar; 31(3):795-801. PubMed ID: 9495263
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats.
    Nakamura Y, Ono H, Zhou X, Frohlich ED.
    Hypertension; 2001 May; 37(5):1262-7. PubMed ID: 11358938
    [Abstract] [Full Text] [Related]

  • 7. Renal cortex remodeling in nitric oxide deficient rats treated with enalapril.
    Barbuto N, Almeida JR, Pereira LM, Mandarim-de-Lacerda CA.
    J Cell Mol Med; 2004 May; 8(1):102-8. PubMed ID: 15090265
    [Abstract] [Full Text] [Related]

  • 8. Protection against L-NAME-induced reduction in cardiac output persists even after cessation of angiotensin-converting enzyme inhibitor treatment.
    Biwer LA, Broderick TL, Xu H, Carroll C, Hale TM.
    Acta Physiol (Oxf); 2013 Jan; 207(1):156-65. PubMed ID: 22834875
    [Abstract] [Full Text] [Related]

  • 9. Beneficial effect of enalapril in spontaneously hypertensive rats cardiac remodeling with nitric oxide synthesis blockade.
    de Andrade Zorzi RL, Meirelles Pereira LM, Mandarim-de-Lacerda CA.
    J Cell Mol Med; 2002 Jan; 6(4):599-608. PubMed ID: 12611644
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enalapril attenuates cardiorenal damage in nitric-oxide-deficient spontaneously hypertensive rats.
    Pereira LM, Bezerra DG, Machado DL, Mandarim-de-Lacerda CA.
    Clin Sci (Lond); 2004 Mar; 106(3):337-43. PubMed ID: 14629192
    [Abstract] [Full Text] [Related]

  • 12. Genetic variants on rat chromosome 8 exhibit profound effects on hypertension severity and survival during nitric oxide inhibition in spontaneously hypertensive rats.
    Schulz A, Schütten-Faber S, Schulte L, Unland J, Kossmehl P, Kreutz R.
    Am J Hypertens; 2014 Mar; 27(3):294-8. PubMed ID: 24363279
    [Abstract] [Full Text] [Related]

  • 13. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK, Drew GM.
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [Abstract] [Full Text] [Related]

  • 14. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X, Matavelli LC, Ono H, Frohlich ED.
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.
    Benter IF, Francis I, Cojocel C, Juggi JS, Yousif MH, Canatan H.
    Auton Autacoid Pharmacol; 2005 Oct; 25(4):143-54. PubMed ID: 16176445
    [Abstract] [Full Text] [Related]

  • 19. Veratric acid, a phenolic acid attenuates blood pressure and oxidative stress in L-NAME induced hypertensive rats.
    Saravanakumar M, Raja B.
    Eur J Pharmacol; 2011 Dec 05; 671(1-3):87-94. PubMed ID: 21937012
    [Abstract] [Full Text] [Related]

  • 20. Chronic NOS Inhibition Affects Oxidative State and Antioxidant Response Differently in the Kidneys of Young Normotensive and Hypertensive Rats.
    Majzunova M, Kvandova M, Berenyiova A, Balis P, Dovinova I, Cacanyiova S.
    Oxid Med Cell Longev; 2019 Dec 05; 2019():5349398. PubMed ID: 31885800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.